Brief: Laurus Labs Signs Investment Agreement With Immunoadoptive Cell Therapy
31/05/2023 12:27
May 31 (Reuters) - Laurus Labs Ltd LAUL.NS :
* SIGNED INVESTMENT AGREEMENT WITH IMMUNOADOPTIVE CELL
THERAPY
* TO FURTHER ACQUIRE 7.24% STAKE FOR CONSIDERATION OF ABOUT
800
MILLION RUPEES
Source text for Eikon: ID:
Further company coverage: LAUL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Laurus Labs
See all newsIndia's Laurus Labs hits record high as Q2 profit more than doubles
Brief: Laurus Labs Declares Dividend Of 1 Rupee Per Share
Brief: Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue
Brief: Laurus Labs Invests 120.96 Million Rupees In Kurnool Renewables Via Rights Issue
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig